Purchases and Sales Made in Q4 2023 in Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO) during Q4 2023. The information is specifically focused on institutions that hold shares of BridgeBio Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 29, 2025
Q4 2023
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-38.9K- 28.63% |
$934K - $1.71M
|
97K
$3.64M
|
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-41.2K- 24.64% |
$989K - $1.81M
|
126K
$4.73M
|
|
|
Feb 14, 2024
Q4 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-43K- 75.01% |
$1.03M - $1.89M
|
14.3K
$537K
|
|
|
Feb 14, 2024
Q4 2023
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-45.4K- 57.69% |
$1.09M - $1.99M
|
33.3K
$1.25M
|
|
|
Feb 14, 2024
Q4 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-63.4K- 18.35% |
$1.52M - $2.78M
|
282K
$10.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-71.1K- 62.84% |
$1.71M - $3.12M
|
42K
$1.58M
|
|
|
Feb 14, 2024
Q4 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-80.9K- 25.48% |
$1.94M - $3.55M
|
236K
$8.87M
|
|
|
Feb 13, 2024
Q4 2023
|
Sio Capital Management, LLC
New York, NY |
SELL
|
- |
-91.2K- 40.9% |
$2.19M - $4M
|
132K
$4.94M
|
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-125K- 76.74% |
$3M - $5.49M
|
37.9K
$1.42M
|
|
|
Feb 14, 2024
Q4 2023
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-144K- 11.5% |
$3.45M - $6.31M
|
1.11M
$41.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-159K- 5.84% |
$3.81M - $6.97M
|
2.56M
$96M
|
|
|
Feb 14, 2024
Q4 2023
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-167K- 92.81% |
$4.02M - $7.34M
|
13K
$486K
|
|
|
Feb 14, 2024
Q4 2023
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-177K- 68.88% |
$4.25M - $7.77M
|
80K
$3M
|
|
|
Jan 19, 2024
Q4 2023
|
Portman Square Capital LLP
London, X0 |
SELL
|
- |
-193K- 87.45% |
$4.63M - $8.47M
|
27.7K
$1.04M
|
|
|
Feb 14, 2024
Q4 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-231K- 42.06% |
$5.54M - $10.1M
|
318K
$11.9M
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-300K- 41.46% |
$7.22M - $13.2M
|
424K
$15.9M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-305K- 74.9% |
$7.33M - $13.4M
|
102K
$3.84M
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-310K- 24.3% |
$7.45M - $13.6M
|
967K
$36.3M
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-416K- 31.04% |
$10M - $18.3M
|
925K
$34.7M
|
|
|
Feb 14, 2024
Q4 2023
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-512K- 42.03% |
$12.3M - $22.5M
|
707K
$26.5M
|
|
|
Feb 08, 2024
Q4 2023
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-632K- 87.42% |
$15.2M - $27.7M
|
91K
$3.41M
|
|
|
Feb 14, 2024
Q4 2023
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-836K- 74.24% |
$20.1M - $36.7M
|
290K
$10.9M
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-996K- 81.92% |
$23.9M - $43.7M
|
220K
$8.25M
|
|
|
Feb 14, 2024
Q4 2023
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-1.32M- 28.28% |
$31.7M - $57.9M
|
3.34M
$125M
|
|
|
Feb 14, 2024
Q4 2023
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
SELL
|
- |
-1.39M- 50.0% |
$33.4M - $61.1M
|
1.39M
$52.2M
|